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Abstract
Background: Medically unexplained physical symptoms (MUPS) have a high prevalence in the
general population and are associated with psychiatric morbidity. There are indications that MUPS
are an important determinant of frequent and long-term disability.
The primary objective was to assess the prevalence of MUPS in sick-listed-employees and its
associations with depressive disorders, anxiety disorders, health anxiety, distress and functional
impairment. Secondary objectives were to investigate the classification of the occupational health
physicians (OHPs), their opinions about the causes as well as the attributions of the employee.
Methods: In a cross-sectional study of 489 sick-listed employees from 5 OHP group practices,
MUPS, depressive disorders, anxiety disorders, health anxiety, distress and functional impairment
were assessed with the Patient Health Questionnaire (PHQ), the Whitely Index (WI), the Four-
Dimensional Symptom Questionnaire (4DSQ) and the Short-Form 36 Health Survey (SF-36).
We used a cut off score of 15 on the PHQ for the categorisation of severe MUPS.
The opinions of the OHPs were evaluated by means of a separate questionnaire with regard to the
presence of employees physical symptoms, and the symptoms attributions, and the diagnoses of
the OHPs.
Results: Severe MUPS had a prevalence of 15.1% in this population of sick-listed employees. These
employees had 4-6 times more depressive and anxiety disorders, and were more impaired. Female
gender and PHQ-9 scores were determinants of severe MUPS.
Most of the time the OHPs diagnosed employees with severe MUPS as having a mental disorder.
The employees attributed their physical symptoms in 66% to mental or to both mental and physical
causes.
Conclusion: The prevalence of severe MUPS is higher in long-term sick-listed employees than in
the non-sick- listed working population and at least equals the prevalence in the general practice
population.
Severe MUPS are associated with psychiatric morbidity and functional impairment and must 
therefore be specifically recognised as such. Validated questionnaires, such as the PHQ-15, are 
useful instruments in order to help OHPs to recognise severe MUPS.
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Background
Many studies have reported high prevalence rates for med-
ically unexplained physical symptoms (MUPS), which,
depending on the definition, vary from 10-24% in medi-
cal outpatients, primary care patients and the general pop-
ulation. These studies used the psychiatric definition of
the somatoform disorders [1,2] and sub-threshold forms
of somatoform disorders, such as abridged somatoform
disorder (ASD) and multisomatoform disorder (MSD) [3-
5], which can be seen as disorders with long-lasting and
multiple MUPS. In these studies the patients with somato-
form disorders also had a high prevalence of psychiatric
co-morbidity, especially depression and anxiety disorder
[1-5]. These patients also report functional impairments
in all domains of health-related quality of life [6], and
they have higher rates of unemployment [7].
MUPS, defined as physical symptoms which are not or
insufficiently explained by a somatic disease, are also
often associated with (work-)stress [8,9]. MUPS as symp-
toms must be distinguished from somatisation which
describes a process in which the patient attributes the
physical symptoms to a medical cause and seeks medical
help, but no organic disease can be found [10].
In most studies patients were screened by psychiatrists,
using a psychiatric interview as the golden standard, but
in health care methods must be found that do not involve
extensive and expensive screening by psychiatrists. In
recent years studies have been performed using validated
questionnaires to help doctors in primary care to diagnose
somatoform disorders and MUPS. Examples are the
Patient Health Questionnaire [5,11,12] (PHQ), the Symp-
tom Checklist [13] (SCL-90) and the Four-Dimensional
Symptom Questionnaire [14] (4DSQ). These question-
naires were also used to study the prevalence of MUPS and
psychiatric disorders [11,15].
In the working, non-sick-listed population, low levels of
MUPS and psychiatric co-morbidity have been reported
[14], contrary to the findings in the sick-listed population.
In various studies it has been found that sickness certified
periods lasted longer and were more frequent in employ-
ees with no clear somatic diagnosis for their physical
symptoms [16] and with multiple self-reported health
symptoms [17-20].
These findings give rise to our hypothesis that in the long-
term sick-listed population there is a higher prevalence of
MUPS than in the working population, and that this is
equal to or higher than the prevalence in the general pop-
ulation. The same applies to the levels of associated co-
morbid psychiatry and functional impairment.
Sick leave is a major problem, that is associated with
reduced well-being of the employee and high costs, due to
reduced productivity and replacement [21] of the
employee.
To our knowledge there has been no high quality study
that has evaluated the recognition of MUPS and somatisa-
tion by occupational health physicians (OHPs), com-
pared to validated instruments.
Curative care studies [22-24] show that primary care phy-
sicians have a low level of recognition of somatoform dis-
orders (36-48%) according to the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV) criteria. Patients with MUPS have symptoms of
depression and anxiety in varying rates of prevalence, but
their somatisation [24] and normalising attributional
styles [23] make it difficult for physicians to recognise
depressive and anxiety disorders.
Troublesome in this field is that different approaches (def-
initions of MUPS, somatoform disorders and somatisa-
tion) and different instruments (psychiatric interviews
and questionnaires measuring different categories) are
used. The different approaches make it difficult to com-
pare studies regarding recognition and prevalence rates.
OHPs consider employees' symptoms in a biopsychoso-
cial model as part of their management strategy. Nowa-
days Dutch OHPs are getting more used to the concept of
somatisation as part of a four-dimensional approach, as
advocated by Terluin et al. [25], of common mental disor-
ders (CMD). This approach has been integrated in the
Dutch guideline for OHP management of employees with
CMD [26]. For most Dutch OHPs MUPS is an unknown
concept, and is not included in the current guidelines. We
hypothesised that when identifying psychosocial factors,
usually OHPs would diagnose MUPS as stress-related
mental disorders, but that they would also more diagnose
somatisation as a secondary diagnosis.
The law in the Netherlands states that employees who
report sick must be seen before the sixth week of sick leave
(for the first consultation) by an OHP. The OHP estab-
lishes the diagnosis, the disabilities, and the prognosis for
return to work. The maximum period of sickness certifica-
tion is two years.
In the present paper the research questions are:
1. What is the prevalence of severe MUPS in sick-listed
employees, seen by OHPs, and what are the associations
with depression, anxiety disorders, distress and health
anxiety, duration of sickness absence on the consultation
day and functional impairment?
2. What are the OHPs' diagnoses, what are their opinions
about the causes of severe MUPS, and what are the symp-BMC Public Health 2009, 9:440 http://www.biomedcentral.com/1471-2458/9/440
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tom attributions of the sick-listed employees with severe
MUPS, compared to the symptom attributions of sick-
listed employees with non-severe MUPS?
Methods
Design
The study was designed as a cross-sectional survey.
Selection of employees
Sick-listed employees were included in the study from
April 2006 until December 2007 by 43 OHPs, in 5 group
practices, derived from two large occupational health serv-
ices. The exclusion criteria were:
1) Insufficient mastery of the Dutch language.
2) Consultation by telephone.
Selection of OHPs
We chose a mixture of group practices, providing services
to large organisations (> 500 employees), medium-sized
organisations (75-500 employees) and small organisa-
tions (< 75 employees) from different branches (Table 1).
Study size
In this study population we assumed an equal or higher
prevalence, of at least 10%, than in the primary care pop-
ulation, with a worst acceptable rate being 7%. With a
95% confidence interval, this implies that the sample
should consist of at least 384 employees.
We decided to include at least 40 OHPs, performing 6 ses-
sions, of at least 4 consultations of employees fulfilling
the inclusion criteria. This would result in 960 eligible
employees. Assuming a maximum non-response of 50%
from the employees and a maximum non-response of
15% from the OHPs, at least 408 employees were
expected to be included in the study.
Data-collection
Over a period of six weeks the OHPs were asked to select
a 4-hour consultation session every week on the same day
(i.e. each Monday from 8-12 a.m.). The practice assistants
in the administrative section of the occupational health
service were instructed to invite all sick-listed employees,
who had an appointment for this session to participate in
the study. These employees received the research ques-
tionnaires one week before the actual consultation, or
later if they received the invitation after that time. They
were also requested to give informed consent. The OHPs
were not involved in the selection of the patients.
The questionnaires were collected on the day of the con-
sultation by the researcher (RH), just before the consulta-
tion with the OHP. After the consultation the OHP filled
in the questionnaire about the presence of physical symp-
toms, the diagnosis, the employee's symptom attribu-
tions, and the OHP's own opinion about the causes of the
symptoms.
Employees who had forgotten to bring their questionnaire
were asked to send their questionnaire to the researcher
within one week, otherwise they would be considered as
non-responders, and no reminders were sent.
Measures
a) Questionnaires for the employee
The employees were asked to answer questions about
their socio-demographic variables, MUPS, depression,
anxiety, distress, health anxiety and functional impair-
ment.
MUPS
The Patient Health Questionnaire (PHQ) [5,12,27]
assesses MUPS and symptoms of depression, anxiety, dis-
tress, eating disorder and alcohol abuse. The PHQ-15
assesses MUPS and rates the extent to which the patient
has been bothered during the past four weeks (score 0-2;
not at all bothered to bothered a lot) by 15 common
somatic symptoms (e.g. fatigue, dizziness, headache) that
rarely have organic explanations.
The total PHQ-15 score range from 0-28 for men and 0-30
for women. For the diagnosis of a somatoform disorder a
Table 1: Study population
OHP group practice 1a 2b 3a 4a 5b
Employees (n) 85 87 108 98 111
OHPs (n) 13 7 6 8 9
Size organizations
(nr of employees)
> 500 > 500 < 75 < 75; 75-500 > 500
Main branches public services,
education and health services
government all types all types Public and financial services, local government
Area Urban Urban Rural Mixed Urban
a = Arboned; b = Achmea VitaleBMC Public Health 2009, 9:440 http://www.biomedcentral.com/1471-2458/9/440
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clinician's assessment is required, but high correlation has
been reported between the PHQ-15 score and clinician-
rated symptoms of somatoform disorder [28]. Kroenke
indicated cut-off scores of 5, 10 and 15 for mild, moderate
and severe MUPS. The cut-off point of 15 (PHQ-15 ≥ 15)
is comparable with clinically representative samples of
MUPS [5,27]. Patients with a PHQ score < 15 are
described as patients with non-severe MUPS, indicating
they have moderate, mild or no MUPS. In this study we
compare employees with severe MUPS with employees
with non-severe MUPS. Kroenke found in a primary care
population a prevalence of 9% and in a secondary care
population a prevalence of 10% of severe MUPS [5].
The internal consistency of the PHQ-15 is satisfactory
(Cronbach's a = 0.80) [12,28]. The test-retest reliability in
a high risk primary care population was moderate with
0.60 [12]. Although limited research has been done, these
figures indicate a valid and moderately reliable question-
naire for detection of patients at risk for somatoform dis-
orders [5,12,27,28].
We also used the Four-Dimensional Symptom Question-
naire (4DSQ) to measure MUPS. This Dutch self-report
questionnaire [14,25] assesses the dimensions of distress,
MUPS, anxiety and depression. The questionnaire is inter-
nally consistent, with Cronbach's alpha coefficients from
.79 (anxiety), to .90 (distress) assessed in a working pop-
ulation [14], without sick-listed employees (personal
information). The Cronbach's alpha coefficient was 0.80
for MUPS, assessed in a working population. Compared
to the diagnosis of General Practitioners (GPs) of somati-
sation, the Area Under the Curve (AUC) was 0.62 [25]. We
used the MUPS subscale of the 4DSQ, in addition to the
PHQ-15, to allow comparison of our findings with other
studies among employees, since to our knowledge there
are no studies which used the PHQ-15 in a working pop-
ulation.
Depression
The PHQ-9 was used to assess symptoms of depression
[29,30]. The rating is comparable with the PHQ-15. Two
questions (feeling tired and having trouble sleeping) in
the PHQ-9 are also included in the PHQ-15. Although
this makes the PHQ-9 score less independent of the PHQ-
15 score, high construct validity and strong associations
with clinical variables in the general population are found
[31]. Compared to the Hospital Anxiety Depression Scale
(HADS) the PHQ-9 categories a higher proportion with
moderate or severe depression [32].
Total PHQ-9 score ranges from 0-27, with a cut-off point
of 15 (PHQ-9 ≥ 15) for severe levels of depression. Algo-
rithms are applied to indicate major depressive disorder
or any depressive disorder (excluding the other diagno-
sis).
Anxiety disorders
The PHQ anxiety subscale contains a module for the
assessment of the symptoms of panic disorder and a mod-
ule for symptoms of other anxiety disorders [27]. Algo-
rithms are applied to diagnose panic disorder and other
anxiety disorders. The algorithm for the panic disorder
module has been more validated [27,33] than the algo-
rithm for other anxiety disorders, and has a sensitivity of
75% and a specificity of 96% for diagnosing panic disor-
der [33].
Distress
We used the Four-Dimensional Symptom Questionnaire
(4DSQ) to measure symptoms of distress. The distress
subscale is associated with (job-) stressors and indicators
of strain. The total score for the 16 distress symptoms
range from 0-32, with a cut-off point of 20 for severe levels
of distress [14,25].
Health anxiety
The Whitely index (WI) was used to measure health anxi-
ety. This 14-item self-report questionnaire with yes/no
questions was designed to assess health anxiety [10,34].
Functional impairment
The Dutch translation of the Short Form Health Survey
(SF-36) was used [35] to measure levels of functioning,
perceived disability and health related quality of life. The
SF-36 has high validity [36], and measures eight aspects of
health-related quality of life (physical functioning, role
functioning physical, bodily pain, general health percep-
tions, vitality, social functioning, role functioning mental
and mental health), with higher scores indicating higher
levels of functioning and well-being.
b) Questionnaire for the OHP
The questionnaire for the OHP contained questions
about:
- the presence of physical complaints (yes/no), as
reported by the employee
- the symptom attribution as reported by the employee
(somatic, mental, or both causes, physiological or not
clear)
- the OHP's diagnosis, with one classification accord-
ing to the CAS classification (classification for occupa-
tional health and social insurance), derived from the
IDH classification (international standard for diagnos-
tic classification).
- the opinion of the OHP about the causes of the
symptoms (somatic disorder, distress, psychiatric dis-
order, hypochondriasis or somatisation). Example of a
question is: 'Do you think that the physical symptomsBMC Public Health 2009, 9:440 http://www.biomedcentral.com/1471-2458/9/440
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of the employee are explained by distress?' The OHP
was asked whether one or more explanations were
present. The questions had a 4-point answering scale:
completely, partly, (almost) not and unclear
The OHPs also filled in a questionnaire with regard to
their personal socio-demographic status.
c) Registrations
Data on sick report and return to work (RTW) were col-
lected from the computerized registration of the two par-
ticipating occupational health services.
Data analyses and statistics
A non-response analysis was performed on age, gender,
level of educational, ethnicity and duration of sick leave
on the day of the consultation.
The cut-off point for the MUPS score (PHQ-15) was set at
15. The data were dichotomized revealing a PHQ ≥ 15
group (the PHQ 15+ group) and a PHQ <15 group (the
PHQ 15- group). Chi-square tests were performed for cat-
egorical variables, and Fischer's Exact Tests were per-
formed when more than 20% of the expected cell
frequencies were less than 5. Chi-square tests for trend for
ordinal variables were performed. Independent Students'
t tests were performed for continuous and Mann-Whitney
U tests for non-parametric distributions.
The SF-36 scores were compared for the PHQ 15+ and
PHQ 15- group with respectively no psychiatric morbid-
ity, one psychiatric disorder, mixed psychiatric morbidity
(one depressive and one anxiety disorder) and three psy-
chiatric disorders (major or other depressive disorder,
panic disorder and other anxiety disorder). We performed
a multivariate (MANOVA) and univariate analyses with
the 8 SF-36 levels as dependent variables.
Psychiatric morbidity (0, 1, 2 and 3 disorders) and the
PHQ score (15+ and 15- group) were the independent
variables and we adjusted for gender, age and ethnicity.
Also the interaction between psychiatric morbidity and
the PHQ score was tested. If influence of the psychiatric
morbidity was found we performed posthoc analyses. We
also reported R2, which estimates the proportion of
explained variance.
To identify the determinants of the PHQ score a logistic
regression model was conducted. In this model with the
PHQ score as the dependent variable, based on the litera-
ture [1-7]. As independent variables were chosen: gender,
age, ethnicity, group practice, attribution of the employee,
PHQ-9, WI, distress, panic disorder and anxiety disorder.
The Hosmer and Lemeshow Goodness-of-Fit test was
applied, which divides subjects into ten equally sized
groups, based on predicted probabilities and computes a
Chi-square from observed and expected frequencies. If the
p-value of the Hosmer and Lemeshow Goodness-of-Fit
was .05 or less we rejected the zero hypothesis that there
is no difference between the observed and the predicted
values of the dependent variable. A high significance level
implies a good fit of the model. We also report the
Nagelkerke R2, which estimates the proportion of
explained variance in a logistic regression model.
All analyses were performed in SPSS for Windows 15.0.
Ethical approval was obtained form the Medical Ethics
Committee of the University Medical Center in Gronin-
gen, who informed us that ethical clearance was not
required because only self-report questionnaires were
used and the study reports at group level.
Results
The eligible study population consisted of 812 sick-liste-
demployees; 489 employees completed the question-
naires (response rate: 60.2%).
Non-responders were comparable to responders with
regard to gender and duration of sick leave on the day of
the consultation, but the non-responders were younger
(mean 41.7 years vs. 44.6 years, p = 0.001). We found a
prevalence rate of 15.1% (n = 74) for severe MUPS. See
Figure 1.
The characteristics of the employees in the PHQ 15+
group and the PHQ 15- group are presented in Table 2. In
the PHQ 15+ group females were over-represented (p =
0.008). The employees in the PHQ 15+ group were about
4 to 6 times more likely to have symptoms of a major
depressive disorder, panic disorder and other anxiety dis-
orders, compared to the employees in the PHQ 15- group.
Levels of health anxiety and distress were higher in the
PHQ 15+ group. The mean levels of MUPS in the PHQ
15+ group were 19.2 (SD 2.6) as measured with the PHQ
and measured with the 4 DSQ 22.6 (SD 5.5), for depres-
sion (PHQ-9) 16.5 (SD 5.4) and for distress (4DSQ) 22.6
(SD 5.5).
In the PHQ 15+ group mental diagnoses were more fre-
quently diagnosed and musculoskeletal disorders less
than in the PHQ 15- group. Posthoc analysis showed that
adjustment disorders were more diagnosed than psychiat-
ric disorders in the PHQ 15+ group.
On average the consultation took place after a median
period of sick leave of 123 days, and a mean period of sick
leave of 185 days (SD 207.5), with a trend that employees
in the PHQ 15+ were sick-listed for a longer period (Table
2).BMC Public Health 2009, 9:440 http://www.biomedcentral.com/1471-2458/9/440
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Quality of life and levels of functioning of the employees
with severe MUPS were lower than that of the employees
with moderate, mild or non MUPS in all domains of the
SF-36. The results are presented in Table 3. In the PHQ
15+ group without psychiatric morbidity, levels of func-
tioning especially in the domains of general health per-
ceptions (p = 0.001), vitality (p = 0.001) and mental role
functioning (p = 0.002) were lower than in the PHQ 15-
group without psychiatric morbidity.
Multivariate analysis showed that psychiatric co-morbid-
ity had an overall effect of reduced functioning (p <
0.001) and that severe MUPS (PHQ 15+) also resulted in
reduced functioning (p < 0.001); gender was the only con-
founder (p = 0.028). The effect of psychiatric co-morbid-
ity was higher on reducing functioning in the PHQ 15+
group than in the PHQ 15-group (interaction effect: p =
0.016). The R2 for our model was 0.551.
Posthoc analysis showed that employees with a PHQ 15+
score with one psychiatric disorder had a higher level of
impairment in most domains than employees with a PHQ
15- score with one psychiatric disorder. In the PHQ 15+
group, more psychiatric disorders did not contribute sub-
stantially to the levels of impairment, except for vitality,
social functioning and mental health.
In the PHQ 15- group, the pattern was different: general
health perceptions and the mental domains of reduced
functioning correlated with the number of co-morbid dis-
orders. Physical functioning was not influenced by psychi-
atric morbidity.
Of the sick-listed employees 89.5% told the OHP that
they had physical symptoms. The causes to which the
employees attributed the physical complaints are also
shown in Table 2. In the PHQ 15+ group the number of
physical complaints was comparable to that in the PHQ
15- group. In the severe MUPS group, attribution to phys-
ical causes was lower and attribution to mental causes was
higher.
The OHP categorisation of somatisation was low: 35.9%
of the employees of the PHQ 15+ group were partly or
completely indicate as somatisers. In contrast 27.9% of
the employees in the PHQ 15- group were partly or com-
Flow chart regarding response and prevalence in group practices and total Sample Figure 1
Flow chart regarding response and prevalence in group practices and total Sample.
Eligible employees of 
5 OHP group 
practices: 
 
1:  n= 131 
2:  n= 107 
3: n= 179 
4:  n= 180 
5: n= 215 
 
Total N= 812
Prevalence severe 
MUPS (%) 
 
1: n=12 (14%) 
2:  n= 9 (10%) 
3: n=12 (11%) 
4: n= 22 (22%) 
5: n=19 ( 9%) 
 
Total N=74 (15.1%)
Prevalence moderate, 
mild or no MUPS (%)
 
1: n=73 (86%) 
2: n=78 (90%) 
3: n=96 (89%) 
4: n=76 (78%) 
5: n=92 (91%) 
 
N=415 (84.9%) 
Responders (%) 
 
1: n= 85 (65%) 
2: n= 87 (81%) 
3: n=108 (60%) 
4:n=  98 (54%) 
5:n=111 (52%) 
 
Total N=489 (60.2%)BMC Public Health 2009, 9:440 http://www.biomedcentral.com/1471-2458/9/440
Page 7 of 13
(page number not for citation purposes)
pletely indicated as somatisers. If both MUPS and somati-
sation would have been one concept (which they are not),
this would have resulted in a sensitivity of 0.36 (95% CI
0.25-0.49) and a specificity of 0.72 (0.67-0.77).
Posthoc analysis (see Table 4) showed that attribution of
the OHP to somatic causes and distress was influenced by
the presence of psychiatric co-morbidity. More than one
psychiatric co-morbid disorder added to the OHP's opin-
ion of somatic causes being less likely and distress more
likely in the PHQ 15+ and PHQ 15- group and psychiatric
causes more likely in the PHQ 15- group. This pattern was
not found with regard to the causes of somatisation and
hypochondriasis in both groups, and psychiatric causes in
the PHQ 15+ group.
With regard to the opinion of the employee more than
one psychiatric co-morbid disorder added to the opinion
of mental causes being less likely, physical and both
causes more likely in the PHQ 15+ and 15- group.
The logistic regression model with PHQ as dependent var-
iable showed that gender of the employee was a determi-
nant, as known from literature. After correction for socio-
demographic variables and variation among the popula-
tion from the different group practices, the score for
depressive symptoms (PHQ-9) also appeared to be a
determinant, in contrast to the other independent varia-
bles. The total explained variance, according to
Nagelkerke R2, was 0.55. The results are shown in Table 5.
Discussion
Prevalence of severe MUPS in sick-listed employees
Our data show that severe MUPS, measured with the
PHQ-15, have a prevalence of 15.1% in the sick-listed
population. Compared to the findings of Kroenke [5] in a
Table 2: Severe MUPS and univariate associations with socio-demographic variables, psychiatric morbidity, health anxiety, distress, 
OHP diagnosis, attribution employee and duration of sickness absence on consultation day
PHQ 15+
N = 74
PHQ 15-
N = 415
p-valuea
Female % 73.0 56.6 0.008
Age mean (SD) 42.5 (9.2) 45.0 (10.0) 0.040c
Education %
High/average/low
20.0/55.7/24.3 35.5/44.4/19.6 0.031b
Autochtone % 75.3 88.6 0.003
Married/living together/alone % 46.6/11.0/42.5 57.7/14.7/27.6 0.038
PHQ-15 mean (SD) 19.2 (2.6) 8.2 (3.9) <0.001d
Major depressive disorder % 64.9 14.7 <0.001
Other depressive disorder % 10.8 13.5 0.528
PHQ-9 mean (SD) 16.5 (5.4) 7.2 (5.6) <0.001d
Panic disorder % 21.6 3.6 <0.001
Other anxiety disorder % 44.6 10.6 <0.001
4DSQ severe MUPS mean (SD) 22.6 (5.5) 9.4 (6.0) <0.001d
Whitely Index (health anxiety) mean (SD) 7.0 (2.9) 4.1 (2.9) <0.001d
Physical symptoms % 94.5 88.6 0.128
OHP diagnosis*(%)
Mental disorder 62.2 39.8 <0.001
Musculoskeletal disorder 10.8 29.6 <0.001
Other disorder 27.0 30.6 0.537
Attribution** employee toa (%):
Physical causes
30.4 54.3 p < 0.001
Mental causes 26.1 15.4 p = 0.031
Both causes 40.6 23.7 p = 0.004
Physiological causes 1.4 6.1 p = 0.118
Do not know 1.4 0.6 P = 0.407
Duration of sick leave (days) on day of
consultation
Median 135 121 0.248d
Mean (SD) 238.7 (283.2) 176.1 (190.4)
* CAS-classification of OHP
** For employees with physical complaints
a X2 test; b X2 trend test;c Independent Students' t test;d Mann-Whitney U testBMC Public Health 2009, 9:440 http://www.biomedcentral.com/1471-2458/9/440
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primary care population and medical outpatients as
assessed by the PHQ-15, the prevalence in our sample of
sick-listed employees was higher. In the primary care pop-
ulation [2] and the general population [3] prevalences of
16% respectively 22% for somatoform disorders have
been found. In the primary care population a prevalence
of 16% was found for somatoform disorders with undif-
ferentiated somatoform disorder (prevalence 13%) as the
most frequent disorder, indicating that patients with this
disorder were bothered by MUPS for longer than 6
months. Although we only studied employees who indi-
cated that they had been bothered by severe multiple
MUPS for 4 weeks, and we performed no medical exami-
nations, the prevalence rates may be compared, assuming
that the long-term sick-listed population had severe
MUPS for longer than 4 weeks. In the study among the
general population [3] the diagnosis of ASD was used,
defined as 4-6 periods of MUPS in a life-long period.
Therefore we can make no comparisons because informa-
tion about the life-long medical history of the employees
in our study was lacking. The mean MUPS score (11.4 on
the 4 DSQ, SD 7.5) is substantially higher than the score
Table 3: Associations of severe MUPS and psychiatric morbidity with functional limitations
SF-36 scale mean (SD) Total population PHQ 15+ PHQ 15-
Study population n = 489 n = 74 n = 412
Without a depressive or anxiety disorder n = 298 n = 13 n = 285
With only 1 depressive or 1 anxiety disorder n = 116 n = 26 n = 90
With only 1 depressive and 1 anxiety disorder n = 62 n = 26 n = 36
With 3 mental disorders n = 13 n = 9 n = 4
SF physical functioning 69.0 (24.6) 55.3 (24.0) 71.6 (23.8)
71.5 (23.4) 72.7 (16.8) 71.5 (23.7)
67.0 (26.2) 47.7 (23.0) 72.7 (24.4)
62.6 (24.8) 54.4 (22.7) 68.7 (24.7)
61.5 (27.4) 55.0 (29.8) 76.3 (14.9)
SF role functioning physical 26.1 (36.2) 12.7 (28.0) 28.4 (37.0)
30.1 (37.7) 14.6 (29.1) 30.7 (37.9)
20.4 (32.0) 4.8 (14.2) 25.0 (34.3)
18.3 (33.8) 18.0 (34.2) 18.6 (33.9)
20.8 (39.6) 18.8 (37.2) 25.0 (50.0)
SF bodily pain 53.3 (27.7) 36.6 (22.8) 56.3 (27.5)
57.4 (28.1) 47.9 (15.7) 57.8 (28.5)
48.9 (25.7) 30.5 (19.2) 54.2 (24.9)
44.0 (25.0) 40.0 (26.6) 46.9 (23.8)
42.4 (31.0) 27.9 (23.3) 75.0 (19.0)
SF general health perceptions 54.2 (20.2) 38.2 (15.0) 57.0 (19.7)
60.1 (18.9) 46.5 (12.3) 60.7 (18.9)
47.1 (19.6) 35.8 (12.1) 50.4 (20.1)
43.7 (17.4) 39.8 (17.5) 46.5 (17.0)
31.5 (11.8) 28.9 (12.9) 37.5 (6.5)
SF vitality 44.6 (22.2) 26.6 (16.8) 47.9 (21.6)
55.2 (19.5) 38.1 (14.7) 56.0 (19.3)
31.8 (14.8) 34.0 (15.4) 31.2 (14.7)
22.6 (13.8) 15.6 (11.3) 27.6 (13.3)
21.9 (14.4) 20.6 (17.0) 25.0 (5.8)
SF social functioning 53.6 (26.8) 36.8 (25.2) 56.6 (26.0)
63.8 (24.3) 57.7 (24.8) 64.1 (24.3)
41.3 (22.9) 40.4 (23.8) 41.6 (22.8)
33.7 (19.8) 29.3 (20.6) 36.8 (18.9)
23.1 (23.3) 18.1 (20.8) 34.4 (27.7)
SF role functioning mental 52.6 (44.9) 19.3 (36.3) 58.3 (43.7)
71.3 (39.5) 38.9 (39.8) 72.7 (38.9)
30.3 (40.3) 24.0 (41.4) 32.2 (40.1)
10.6 (23.4) 4.2 (20.4) 14.8 (24.5)
19.4 (33.2) 20.8 (39.6) 16.7 (19.2)
SF mental health 60.7 (23.2) 41.1 (22.2) 64.2 (21.6)
73.5 (16.2) 65.2 (13.0) 73.8 (16.3)
47.7 (16.4) 51.4 (17.2) 46.6 (16.1)
31.7 (13.7) 25.2 (11.7) 36.3 (13.4)
23.4 (17.3) 22.2 (19.7) 26.0 (12.4)BMC Public Health 2009, 9:440 http://www.biomedcentral.com/1471-2458/9/440
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found by Terluin (3.7 on the 4 DSQ, SD 4.1) in a working,
non-sick-listed population [25]. On the one hand it
should be taken into account that the median duration of
sick leave was 123 days and a mean duration of 185 days
(SD 207.5), indicating a selection of employees with a dif-
ficult RTW process. On the other hand, MUPS were not
associated with the duration of sick leave on the day of the
consultation. This may indicate that MUPS are already a
serious problem when employees consult the OHP
because they are sick-listed.
The prevalence we found is based on a sample of employ-
ees, 89% of whom reported one or more physical com-
plaints. This is comparable to the rate of 86% found in a
general practice population by Van der Windt [37].
Our conclusions are that the prevalence of severe MUPS in
the sick-listed population is substantially higher than in
the working population, that it is at least equal to the prev-
alence in the general practice population and that it might
be even higher.
Associations with psychiatric morbidity, health anxiety 
and distress
MUPS are associated with high levels of major depression,
panic disorder and other anxiety disorders. This is in line
with the findings in the general population [1-3], but the
percentage of employees with severe MUPS without psy-
chiatric morbidity is lower among sick-listed employees
than in the general population.
Table 4: Associations of severe MUPS and psychiatric morbidity with attribution of physical symptoms by employees and OHPs
PHQ 15+ PHQ 15+
Study population* n = 69 n = 365
Without a depressive or anxiety disorder = 0 n = 13 n = 260
With 1 depressive or 1 anxiety disorder = 1 n = 24 n = 74
With 2 or 3 mental disorders = 2-3 n = 32 n = 31
Attribution employee to (%):
Physical causes 0 23.1 10.5
1 8.3 24.3
2-3 40.6 35.5
Mental causes 0 46.2 64.0
1 50.0 35.1
2-3 9.4 19.4
Both causes 0 23.1 19.0
1 37.5 32.4
2-3 50.0 41.9
Physiological causes 0 0.0 6.2
1 4.2 6.8
2-3 0.0 3.2
Employee does not know 0 7.7 0.4
1 0.0 1.4
2-3 0.0 0.0
OHP attribution of symptoms completely/partly to (%):
Somatic causes 0 46.2/30.8 59.0/16.3
1 37.5/29.2 23.3/34.2
2-3 6.7/20.0 16.1/25.8
Psychiatric causes 0 23.1/15.4 4.8/9.6
1 16.7/25.0 19.2/24.7
2-3 33.0/33.0 25.8/38.7
Distress 0 38.5/30.8 20.7/16.3
1 12.5/29.2 28.8/46.6
2-3 55.2/20.7 41.9/25.8
Health anxiety 0 15.4/23.1 1.2/15.5
1 4.2/20.8 8.2/13.7
2-3 6.7/46.7 3.2/38.7
Somatisation 0 0.0/38.5 4.8/18.7
1 8.3/25.0 8.2/27.4
2-3 6.7/30.0 9.7/35.5
*) For sick-listed employees with physical complaintsBMC Public Health 2009, 9:440 http://www.biomedcentral.com/1471-2458/9/440
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The algorithms used in the PHQ-9 indicate that the diag-
nosis of major depressive disorder excludes the diagnosis
of other depressive disorders, which explains the low
prevalence of the latter in our findings. We also found that
employees with severe MUPS experienced high levels of
health anxiety and distress, but the cause of the distress
cannot be derived from our data.
The logistic regression model showed that distress and
health anxiety were not determinants of the PHQ-15
score, in contrast to the depression score. Patients often
present the physical symptoms of their depression, and
our data confirm this overlap of depression and MUPS in
sick-listed employees. The OHPs recognised a high level
of mental disorders, although not very specific because
they more often diagnosed adjustment disorders than
depressive disorders and anxiety disorders. The attribu-
tion of the employee could have influenced these diag-
noses.
Associations of severe MUPS and psychiatric co-morbidity 
with functional limitations
Compared to the findings of Kroenke [6] in a general prac-
tice population, severe MUPS had more impact on func-
tioning in sick-listed employees: the SF-36 scores in our
study were lower for all domains. Psychiatric morbidity
adds to this effect, in line with the findings of Van de Waal
et al. [2].
In sick-listed employees it also seems that severe MUPS,
especially when accompanied by a psychiatric disorder,
impairs functioning to such an extent that multiple psy-
chiatric co-morbidity has no additional effect on most
domains of functioning. This is in line with the findings
of Barsky [15] i.e. that in primary care patients severe
MUPS resulted in increased medical consumption and
costs, but there was no further increase due to psychiatric
morbidity. These findings imply that recognising MUPS
and psychiatric co-morbidity are important for the OHPs,
because of the impact on functioning.
Recognition by the OHP
The OHPs' recognition of somatisation, compared to the
PHQ-15 score, was low. The OHPs did not consider this
as a primary or secondary cause of the symptoms. Because
they diagnosed most often a mental disorder, with a
stress-related cause, our conclusion is that for the OHPs
the concept of somatisation is not related to severe MUPS.
Therefore, our hypothesis that OHPs would recognise
employees with severe MUPS more often as somatisers
was not confirmed.
We did not ask the OHPs if they diagnosed MUPS, but in
employees with severe MUPS they less often found a
somatic explanation for employees with severe MUPS
than in employees with moderate, mild or no MUPS.
Hence our recommendation is that the concept of MUPS
should be introduced to OHPs in guidelines and training.
Van Ravestijn et al. [12] found a low predictive value of
the PHQ-15, which indicates that in the PHQ 15+ group
the employees often had other diagnoses as depression
and anxiety disorder. Indeed, our data pointed out that
Table 5: Logistic regression model for PHQ-15 score as dependent variablea
Independent variables OR 95% CI lower 95% CI upper Signif.
Female gender 3.51 1.41 8.78 0.007
Age (per year) 0.98 0.94 1.02 0.405
AutochthonsB 0.44 0.16 1.27 0.129
Group practice 0.332
Group practice 1 0.53 0.11 2.45 0.413
Group practice 2 0.70 0.21 2.34 0.559
Group practice 3 0.44 0.14 1.45 0.178
Group practice 4 1.43 0.52 3.94 0.493
PHQ-9 1.20 1.08 1.33 0.001
Whitely Index 1.12 0.97 1.28 0.116
Stressc 1.63 0.94 2.82 0.082
PHQ panic disorder 2.39 0.68 8.46 0.176
PHQ other anxiety disorders 1.20 0.46 3.12 0.709
Attribution employee to: 0.658
- mental causes 0.62 0.19 1.98 0.418
- physical and mental causes 0.66 0.24 1.80 0.413
- physiological causes 0.28 0.03 2.98 0.290
a) For sick-listed employees with physical complaints; b) born in the Netherlands; c) per 8 points on the 4DSQ.
Hosmer & Lemeshow test: N = 386 chi2 = 5.0 df = 8 p = 0.756
Nagelkerke R2 = 0.55BMC Public Health 2009, 9:440 http://www.biomedcentral.com/1471-2458/9/440
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OHPs often diagnosed a mental disorder in the PHQ 15+
group.
In our sample, higher scores for depression contributed to
a higher MUPS score. This psychiatric morbidity was not
sufficiently recognised by the OHP, but it is well known in
general practice [2], and is also in line with the findings of
Clarke and Kessler i.e. that somatisation [24] and normal-
ising attributions [23] hamper the recognition of depres-
sion and anxiety.
A point of interest is that many employees with severe
MUPS did not attribute their physical symptoms to
somatic causes only. This contributes to the growing evi-
dence that 'the somatic pathway' in the doctor-patient
communication is not mainly due to the somatic attribu-
tions of patients [38], and that the concept of somatisa-
tion should be applied on another level. Our data further
show that more than one psychiatric co-morbid disorder
influences the opinion of the employee with severe MUPS
by finding only mental causes less likely and physical
causes more likely, but also finding both causes more
likely. When more than one psychiatric disorder is present
the OHP finds somatic causes less likely and distress a
more likely cause, but still not labels this as somatisation.
Further conclusion is that in case of sick-listed employees
with severe MUPS and more psychiatric co-morbid disor-
ders there is a potential of difficulties between OHP and
employee with regard to management and communica-
tion, because of the different opinions about the causes of
the symptoms.
Somatisation is a specific factor, related to psychiatric co-
morbidity, to the cognitions and coping styles of patients
[38,39] and to factors in the physician-patient relation-
ship [38-40]. Patients with MUPS who attribute their
symptoms solely to a physical cause ('complete somatis-
ers') have a worse prognosis than patients who do so
partly or not at all [38-40]. Our results indicate that OHPs
need more training to distinguish between MUPS, psychi-
atric co-morbidity and the employees attribution.
Strengths and limitations
A strength of our study is that, to our knowledge, this is
the first large scale study in which validated question-
naires have been used to assess severe MUPS and psychi-
atric morbidity in a sick-listed population. The
participation of five different group practices located in
urban and rural sites, and the participation of employees
from small and large companies enhances the generalisa-
bility of the results. Furthermore, this is a cross-sectional
survey in a population with moderate and long-term sick-
ness absence, whereas other studies of sick-listed popula-
tions focused on diagnoses in employees with lasting
impairment.
Another strong point is that we could compare the infor-
mation gathered, by means of psychometrically validated
questionnaires as reference test, to the diagnoses of the
OHPs as well as to the opinions of the employees.
A limitation of a cross-sectional study, is that no conclu-
sions can be drawn with regard to the underlying causes
of severe MUPS. This is especially important with regard
to the associations between severe MUPS on the one
hand, and psychiatric co-morbidity, distress and health
anxiety on the other hand.
Self-report questionnaires were used for our main out-
comes, and no medical examination was performed to
find somatic explanations for the multiple physical com-
plaints. However, the questionnaires used were well vali-
dated, and there is sufficient evidence in the literature
exists that a high number of somatic symptoms and PHQ
levels of ≥ 15 indicate that the symptoms should be con-
sidered as MUPS [5,28].
A response rate of 60.2% is only moderate. Nevertheless
this is satisfying compared to response rates, varying from
30-60%, reported in other studies in the working popula-
tion [41,42]. The non-responders were younger than the
responders, which could have contributed to a somewhat
higher prevalence rate in our sample, because the mean
age of employees with severe MUPS tends to be higher
[43]. There were no other indications of selection bias.
Finally, a limitation is that the OHPs were asked about
their attribution of the symptoms to somatisation, and
not about the diagnosis of MUPS. As stated in the back-
ground section this provides only a comparison on this
topic.
Implications for practice
The management of sick-listed employees with severe
MUPS is hampered by low recognition by the OHP. For
the employee it is important that this morbidity is man-
aged. This can be improved by education and training of
the OHP, and by liaison-psychiatric consultation with the
employee. In the occupational health setting self-report
questionnaires such as the PHQ and the 4DSQ may be
useful instruments for the diagnosis of severe MUPS.
Adequate treatment of severe MUPS and adherence to
management guidelines reduce medical consumption,
improve physical functioning and may lead to symptom
reduction [44-46]. If symptoms persists, the most appro-
priate evidence-based interventions, according to reviews
[47,48], are cognitive behavioral treatment and antide-
pressant medication. For persistent health anxiety, cogni-
tive behavioral therapy has been found to be effective
[49].BMC Public Health 2009, 9:440 http://www.biomedcentral.com/1471-2458/9/440
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Our results show that employees with severe MUPS are at
least partly open to other than somatic explanations for
their physical complaints. Training the OHP to explore
the symptom attributions made by the employees might
be worthwhile because this could lead to more adequate
explanation and reassurance [50].
Implications for further research
It is important to monitor the scores of sick-listed employ-
ees with severe MUPS on the course of their complaints
(as to the severity of MUPS, psychiatric morbidity and
functional limitations) after return to work. Such a study
may indicate whether they remain at risk for frequent sick
leave and which determinants are responsible for these
eventual recurrences.
Longitudinal research is needed to find out whether severe
MUPS are a determinant for prolonged sick leave, as
severe MUPS are associated with more functional limita-
tions.
Research is also needed to investigate the process of how
a working employee develops higher scores of MUPS, psy-
chiatric morbidity, distress, and functional limitations,
and as a result reports sick-listed.
Conclusion
Severe MUPS are more prevalent in sick-listed employees
than in the general working population. Severe MUPS are
accompanied by higher levels of psychiatric co-morbidity,
health anxiety and distress in sick-listed employees than
in general practice patients.
Severe MUPS are associated with multiple functional
impairments, but we found indications that it is insuffi-
ciently recognised by the OHP. We recommend that
OHPs receive guidelines, education and training on this
subject, and on the use of questionnaires as instruments
to detect and monitor MUPS.
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